Mar 2026 $38 M Issued in a merger or acquisition $10 to $50 million 59
TMRW Life Sciences, Inc.: Private sale, Mar 2026 × Investors in this round 59 investors had bought by the notice of Apr 24, 2026: 59 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $38 M of $38 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Louis Villalba · Executive Officer, Director Andrew Schwab · Director Emily Drabant Conley · Director Greg Eisner · Director Jeffrey Port · Director Vinay Shah · Director William Schoolcraft · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Louis Villalba, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 24, 2026. Read the notice at the SEC .
equity SEC Jun 2024 $28 M No. 4 $10 to $50 million 69
TMRW Life Sciences, Inc.: Raise no. 4, Jun 2024 × Investors in this round 69 investors had bought by the notice of Jul 12, 2024: 69 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $28 M of $30 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Alan Drabant Murray · Director Andrew Drabant Schwab · Director Emily Drabant Conley · Director Jeffrey Drabant Port · Director Joshua Abram · Director Louis Drabant Villaba · Director Roberta Drabant Myers · Director Vinay Drabant Shah · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Louis Villalba, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 12, 2024. Read the notice at the SEC .
equity SEC Jun 2021 $100 M No. 3 $50 to $250 million 59
TMRW Life Sciences, Inc.: Raise no. 3, Jun 2021 × Investors in this round 59 investors had bought by the notice of May 13, 2022: 59 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $100 M of $102 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Melanie Goldey · Executive Officer Tara Comonte · Executive Officer, Director Alan Murray · Director Andrew Schwab · Director Emily Conley · Director Jeffrey Port · Director Joshua Abram · Director Roberta Myers · Director Vinay Shah · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes amounts paid in both cash and pursuant to conversion of indebtedness.”Signed by Steve Gordon, Chief Legal Officer. Source: SEC Form D and 1 amendment, newest notice filed May 13, 2022. Read the notice at the SEC .
equity SEC Feb 2021 $20 M No. 2 $10 to $50 million 35
TMRW Life Sciences, Inc.: Raise no. 2, Feb 2021 × Investors in this round 35 investors had bought by the notice of Feb 12, 2021: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Alan Murray · Director Andrew Schwab · Director Emily Conley · Director Jeffrey Port · Director Joshua Abram · Director Roberta Myers · Director Tara Comonte · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steve Gordon, Chief Legal Officer. Source: SEC Form D, newest notice filed Feb 12, 2021. Read the notice at the SEC .
debt, options SEC Dec 2019 $37 M No. 1 $10 to $50 million 34
TMRW Life Sciences, Inc.: Raise no. 1, Dec 2019 × Investors in this round 34 investors had bought by the notice of May 19, 2020: 34 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $37 M of $37 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $500,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Alan Murray · Director Andrew Drabant Schwab · Director Emily Drabant Conley · Director Jeffrey Port · Director Joshua Abram · Director Roberta Drabant Myers · Director Tara Comonte · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steve Gordon, Chief Legal Officer. Source: SEC Form D and 1 amendment, newest notice filed May 19, 2020. Read the notice at the SEC .
equity SEC